Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jgar.2020.06.016 http://scihub22266oqcxt.onion/10.1016/j.jgar.2020.06.016 32622008!7328586!32622008     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Glob+Antimicrob+Resist 2020 ; 22 (ä): 680-684 Nephropedia Template TP {{tp|p=32622008|t=2020. Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going |pdf=|usr=}}{{32622008}} gab.com Text Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going JO: J Glob Antimicrob Resist http://www.kidney.de/pget.php?&tw=1&pmid=32622008 #FOAvip * Azithromycin (AZM) is a promising drug candidate for the treatment of the COVID-19. * Studies so far on the use of AZM in COVID-19 patients have various methodological limitations. * The evidence on the efficacy of AZM as an adjunct to hydroxychloroquine for COVID-19 is not enough yet. * Combination of AZM and HCQ should be decided with caution due serious cardiac adverse effects. * Currently, 21 clinical trials are being carried out on the use of AZM in COVID-19. Twit Text FOAVip Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going ????J Glob Antimicrob Resist http://www.kidney.de/pget.php?&tw=1&pmid=32622008 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32622008 #FOAvip English Wikipedia <ref>{{Cite pmid|32622008}}</ref> Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going #MMPMID32622008 Parra-Lara LG; Martinez-Arboleda JJ; Rosso F J Glob Antimicrob Resist 2020[Sep]; 22 (ä): 680-684 PMID32622008show ga * Azithromycin (AZM) is a promising drug candidate for the treatment of the COVID-19. * Studies so far on the use of AZM in COVID-19 patients have various methodological limitations. * The evidence on the efficacy of AZM as an adjunct to hydroxychloroquine for COVID-19 is not enough yet. * Combination of AZM and HCQ should be decided with caution due serious cardiac adverse effects. * Currently, 21 clinical trials are being carried out on the use of AZM in COVID-19. |*Azithromycin[MESH] |*Betacoronavirus[MESH] |*Coronavirus Infections/drug therapy[MESH] |*Pandemics[MESH] |*Pneumonia, Viral[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Humans[MESH] |Hydroxychloroquine[MESH]Azithromycin and SARS-CoV-2 infection: Where we are now and where we a(epmc).pdf DeepDyve Pubget Overpricing